Research ExplorerPublicationsSimilar incidences of TP53 deletions in extramedullary organ...

Similar incidences of TP53 deletions in extramedullary organ infiltrations, soft tissue and osteolyses of patients with multiple myeloma.

Standard

Similar incidences of TP53 deletions in extramedullary organ infiltrations, soft tissue and osteolyses of patients with multiple myeloma. / Billecke, Lisa; Murga-Penas, Eva-Maria; May, Annette M; Engelhardt, Monika; Nagler, Arnon; Leiba, Merav; Schiby, Ginette; Kröger, Nicolaus; Zustin, Jozef; Marx, Andreas; Matschke, Jakob; Tiemann, Markus; Goekkurt, Eray; Bokemeyer, Carsten; Schilling, Georgia.

In: ANTICANCER RES, Vol. 32, No. 5, 5, 2012, p. 2031-2034.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Billecke, L, Murga-Penas, E-M, May, AM, Engelhardt, M, Nagler, A, Leiba, M, Schiby, G, Kröger, N, Zustin, J, Marx, A, Matschke, J, Tiemann, M, Goekkurt, E, Bokemeyer, C & Schilling, G 2012, 'Similar incidences of TP53 deletions in extramedullary organ infiltrations, soft tissue and osteolyses of patients with multiple myeloma.', ANTICANCER RES, vol. 32, no. 5, 5, pp. 2031-2034. <http://www.ncbi.nlm.nih.gov/pubmed/22593484?dopt=Citation>

APA

Billecke, L., Murga-Penas, E-M., May, A. M., Engelhardt, M., Nagler, A., Leiba, M., Schiby, G., Kröger, N., Zustin, J., Marx, A., Matschke, J., Tiemann, M., Goekkurt, E., Bokemeyer, C., & Schilling, G. (2012). Similar incidences of TP53 deletions in extramedullary organ infiltrations, soft tissue and osteolyses of patients with multiple myeloma. ANTICANCER RES, 32(5), 2031-2034. [5]. http://www.ncbi.nlm.nih.gov/pubmed/22593484?dopt=Citation

Vancouver

Billecke L, Murga-Penas E-M, May AM, Engelhardt M, Nagler A, Leiba M et al. Similar incidences of TP53 deletions in extramedullary organ infiltrations, soft tissue and osteolyses of patients with multiple myeloma. ANTICANCER RES. 2012;32(5):2031-2034. 5.

Bibtex

@article{fa36c5c2d44f4dd58ca5914fd4ca93c3,
title = "Similar incidences of TP53 deletions in extramedullary organ infiltrations, soft tissue and osteolyses of patients with multiple myeloma.",
abstract = "Extramedullary (EM) organ impairment in patients with multiple myeloma (MM) is a rare event, occurring mostly during disease relapse after high-dose chemotherapy with autologous or allogeneic stem cell transplantation. This manifestation is commonly associated with an unfavourable outcome. Previous studies suggested a correlation between the clinical course of patients with MM and EM and the cytogenetic findings, e.g. deletion of TP53 on 17p13.",
keywords = "Humans, Male, Aged, Female, Middle Aged, Aged, 80 and over, *Chromosome Deletion, *Chromosomes, Human, Pair 17, *Genes, p53, Multiple Myeloma/complications/*genetics/pathology, Osteolysis/*etiology, Soft Tissue Neoplasms/*genetics/pathology, Humans, Male, Aged, Female, Middle Aged, Aged, 80 and over, *Chromosome Deletion, *Chromosomes, Human, Pair 17, *Genes, p53, Multiple Myeloma/complications/*genetics/pathology, Osteolysis/*etiology, Soft Tissue Neoplasms/*genetics/pathology",
author = "Lisa Billecke and Eva-Maria Murga-Penas and May, {Annette M} and Monika Engelhardt and Arnon Nagler and Merav Leiba and Ginette Schiby and Nicolaus Kr{\"o}ger and Jozef Zustin and Andreas Marx and Jakob Matschke and Markus Tiemann and Eray Goekkurt and Carsten Bokemeyer and Georgia Schilling",
year = "2012",
language = "English",
volume = "32",
pages = "2031--2034",
journal = "ANTICANCER RES",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5",

}

RIS

TY - JOUR

T1 - Similar incidences of TP53 deletions in extramedullary organ infiltrations, soft tissue and osteolyses of patients with multiple myeloma.

AU - Billecke, Lisa

AU - Murga-Penas, Eva-Maria

AU - May, Annette M

AU - Engelhardt, Monika

AU - Nagler, Arnon

AU - Leiba, Merav

AU - Schiby, Ginette

AU - Kröger, Nicolaus

AU - Zustin, Jozef

AU - Marx, Andreas

AU - Matschke, Jakob

AU - Tiemann, Markus

AU - Goekkurt, Eray

AU - Bokemeyer, Carsten

AU - Schilling, Georgia

PY - 2012

Y1 - 2012

N2 - Extramedullary (EM) organ impairment in patients with multiple myeloma (MM) is a rare event, occurring mostly during disease relapse after high-dose chemotherapy with autologous or allogeneic stem cell transplantation. This manifestation is commonly associated with an unfavourable outcome. Previous studies suggested a correlation between the clinical course of patients with MM and EM and the cytogenetic findings, e.g. deletion of TP53 on 17p13.

AB - Extramedullary (EM) organ impairment in patients with multiple myeloma (MM) is a rare event, occurring mostly during disease relapse after high-dose chemotherapy with autologous or allogeneic stem cell transplantation. This manifestation is commonly associated with an unfavourable outcome. Previous studies suggested a correlation between the clinical course of patients with MM and EM and the cytogenetic findings, e.g. deletion of TP53 on 17p13.

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - Chromosome Deletion

KW - Chromosomes, Human, Pair 17

KW - Genes, p53

KW - Multiple Myeloma/complications/genetics/pathology

KW - Osteolysis/etiology

KW - Soft Tissue Neoplasms/genetics/pathology

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - Chromosome Deletion

KW - Chromosomes, Human, Pair 17

KW - Genes, p53

KW - Multiple Myeloma/complications/genetics/pathology

KW - Osteolysis/etiology

KW - Soft Tissue Neoplasms/genetics/pathology

M3 - SCORING: Journal article

VL - 32

SP - 2031

EP - 2034

JO - ANTICANCER RES

JF - ANTICANCER RES

SN - 0250-7005

IS - 5

M1 - 5

ER -